Study on injury for the small intestinal mucosa with the antithrombotic drug therapy after the percutaneous transluminal coronary angioplasty

Study on injury for the small intestinal mucosa with the antithrombotic drug therapy after the percutaneous transluminal coronary angioplasty - Study on injury for the small intestinal mucosa with the antithrombotic drug therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014853

Enrollment

100

Registered

2014-08-13

Start date

2014-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small intestinal mucosal injury

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients that word of mouth and written informed consent were obtained. The patients who take low-dose aspirin continuously.

Exclusion criteria

Exclusion criteria: 1.The patient who cannot swallow it 2.The patient whom the state of the body has bad. 3.The patient who has a pacemaker and other medical equipment in the body. 4.The patient that an agreement of treating it surgically is not provided when a capsule endoscope stayed. 5.The patient who participates in study influencing this study directly or indirectly. 6.The patient who judged that we were inappropriate.

Design outcomes

Primary

Measure	Time frame
Evaluation of the small intestinal injuries induced by chemothelapy	—

Secondary

Measure	Time frame
1.Location and From of small intestinal injuries. 2.We compare the change of Plasma diamioxidase(DAO) activities and calprotectin before and after chemotherapy. 3.We check a correlation with Lewis score in DAO and calprotectin	—

Countries

Japan

Contacts

Public ContactToshihisa Takeuchi

Osaka Medical College Second Dep of Internal Medicine

in2097@poh.osaka-med.ac.jp072-727-1824

Outcome results